Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04410913

Organisation Name: John Wayne Cancer Institute

Overal Status: Not yet recruiting

Start Date: July 2020

Last Update: June 1, 2020

Lead Sponsor: Keith Heinzerling

Brief Summary: Twenty participants, age 18 or older, who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for moderate to severe Alcohol Use Disorder will be randomized to open-label psilocybin (25 mg) therapy with the Visual Healing Set and Setting platform (N=10) versus psilocybin (25 mg) with a standard Set and Setting platform (N=10). The purpose of this study is to evaluate the feasibility, safety, and tolerability of adding Visual Healing, a nature-themed virtual immersive program, to psilocybin-assisted therapy among participants with alcohol use disorder.

Conditions:
  • Alcohol Use Disorder


Total execution time in seconds: 0.20756793022156